SARS-CoV-2 and hepatitis

MeSH terms

• Alanine Transaminase / blood*
• Antiviral Agents / administration & dosage
• Antiviral Agents / adverse effects
• Aspartate Aminotransferases / blood*
• Betacoronavirus* / isolation & purification
• Betacoronavirus* / pathogenicity
• COVID-19
• COVID-19 Drug Treatment
• COVID-19 Testing
• Chemical and Drug Induced Liver Injury* / blood
• Chemical and Drug Induced Liver Injury* / diagnosis
• Chemical and Drug Induced Liver Injury* / etiology
• Chloroquine* / administration & dosage
• Chloroquine* / adverse effects
• Clinical Laboratory Techniques / methods
• Coronavirus Infections* / complications
• Coronavirus Infections* / diagnosis
• Coronavirus Infections* / drug therapy
• Coronavirus Infections* / physiopathology
• Diagnosis, Differential
• Drug Combinations
• Hepatitis, Viral, Human* / blood
• Hepatitis, Viral, Human* / diagnosis
• Hepatitis, Viral, Human* / etiology
• Humans
• Liver / pathology
• Liver Function Tests / methods
• Lopinavir* / administration & dosage
• Lopinavir* / adverse effects
• Male
• Middle Aged
• Pandemics*
• Pneumonia, Viral* / complications
• Pneumonia, Viral* / diagnosis
• Pneumonia, Viral* / physiopathology
• Ritonavir* / administration & dosage
• Ritonavir* / adverse effects
• SARS-CoV-2